[Studies on the understanding of problems of radiologic cytostatic combination treatment. 6. Further syncytostatic studies with 5-fluorouracil, natulan and proresid].
D000577:Amides / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000494:pharmacology; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000494:pharmacology; D004431:Ear, External / Q000293:injuries; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000494:pharmacology; D006097:Granulation Tissue / Q000187:drug effects* / Q000528:radiation effects; D006834:Hydrazines / Q000008:administration & dosage / Q000494:pharmacology; D051379:Mice; D009369:Neoplasms / Q000628:therapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011033:Podophyllin / Q000494:pharmacology / Q000627:therapeutic use; D011035:Podophyllum; D011830:Radiation Effects; D011833:Radiation Injuries, Experimental / Q000188:drug therapy; D011879:Radiotherapy Dosage; D013223:Statistics as Topic; D013623:Tail / Q000528:radiation effects; D014945:Wound Healing / Q000187:drug effects* / Q000528:radiation effects
D000577:Amides; D000970:Antineoplastic Agents; D006834:Hydrazines; D003520:Cyclophosphamide; D011033:Podophyllin; D005472:Fluorouracil
Untersuchungen zum Verständnis der Problematik radiologisch-zytostatischer Kombinationsbehandlung. 6. Weitere synzytostatische Untersuchunge mit 5-Fluoruracil, Natulan und Proresid.